7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Sagar DR et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. 2014 Ann. Rheum. Dis. pmid:23723320
Liu M et al. Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. 2014 Stem Cells Dev. pmid:24007307
Guo L et al. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. 2014 DNA Cell Biol. pmid:24283361
Samara S et al. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. 2014 Exp. Mol. Pathol. pmid:24200492
Casarin RC et al. Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. 2014 Int J Oral Maxillofac Surg pmid:24530035
Lim WH et al. Downregulation of Wnt causes root resorption. 2014 Am J Orthod Dentofacial Orthop pmid:25172256
MacMillan AK et al. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. 2014 Int J Nanomedicine pmid:25506216
Jiang Y et al. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. 2014 J Transl Med pmid:25471933
Titanji K et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. 2014 PLoS Pathog. pmid:25393853
Akiyama N et al. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. 2014 J. Exp. Med. pmid:25385757
Lv Y et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. 2014 BMC Musculoskelet Disord pmid:25377946
D'Abramo A et al. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. 2014 Mediators Inflamm. pmid:25374442
Samir SM and Malek HA Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. 2014 J. Physiol. Pharmacol. pmid:25371528
Arrigoni C et al. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. 2014 Mol. Cancer pmid:25335447
Zhang X et al. Ultrastructural characterization of the implant interface response to loading. 2014 J. Dent. Res. pmid:24389808
Lv Z et al. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. 2014 Oncol. Rep. pmid:24337584
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Hayashida C et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. 2014 J. Biol. Chem. pmid:24610813
Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. 2014 J. Vasc. Res. pmid:24642764
Esteghamati A et al. Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease. 2014 Arch Iran Med pmid:25204474
Jasiewicz M et al. Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. 2014 Pol. Arch. Med. Wewn. pmid:25188298
Genre F et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. 2014 PLoS ONE pmid:25184828
Zhang YD et al. Association of the g.19074G>A genetic variant in the osteoprotegerin gene with bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:25177945
Bandeira F et al. Bone markers and osteoporosis therapy. 2014 Arq Bras Endocrinol Metabol pmid:25166041
Foo JP et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. 2014 J. Clin. Endocrinol. Metab. pmid:25148234
Warren JT et al. Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. 2014 Sci Signal pmid:25140055
Jung Koo H et al. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. 2014 J Ethnopharmacol pmid:24333364
Yan D et al. Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. 2014 J Orthop Surg Res pmid:25138985
Schieferdecker A et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. 2014 Oncotarget pmid:25138051
Bosman MC et al. Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment. 2014 J. Biol. Chem. pmid:24280212
Chung SL et al. Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. 2014 J. Orthop. Res. pmid:25131218
Yoshida S et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. 2014 PLoS ONE pmid:25105978
Kim YH et al. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. 2014 Biomaterials pmid:24125774
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
Loureiro MB et al. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. 2014 Diabetes Res. Clin. Pract. pmid:24529565
Sänger N et al. OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. 2014 Mol Oncol pmid:24785095
Hidayat R et al. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. 2014 Acta Med Indones pmid:24760805
Milanova V et al. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. 2014 Mediators Inflamm. pmid:24757287
Nolen BM et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 2014 PLoS ONE pmid:24747429
Zhao JJ et al. Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:24737508
Yoo YM et al. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. 2014 Int J Mol Sci pmid:24717410
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
Shao X et al. Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. 2014 J Diabetes Res pmid:24812633
Sirjani M et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. 2014 Iran J Allergy Asthma Immunol pmid:24659160
Wang JH et al. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. 2014 J Clin Hypertens (Greenwich) pmid:24640954
Liu YP et al. Association of the g.27563G>A osteoprotegerin genetic polymorphism with bone mineral density in Chinese women. 2014 Genet. Mol. Res. pmid:24615112
Ovchinnikova OA et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. 2014 J. Intern. Med. pmid:24588843
Guo L et al. Effects of erythropoietin on osteoblast proliferation and function. 2014 Clin. Exp. Med. pmid:23135151
Navratilova Z et al. Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:22660233

Table of Content